Faculty Support

Building a Culture of Impact

Angela Kashuba, Pharm.D., is a perfect example of the critical role UNC Eshelman School of Pharmacy plays in advancing disease treatment.

Angela Kashuba, Pharm.D., is a perfect example of the critical role UNC Eshelman School of Pharmacy plays in advancing disease treatment.

By carstories

Angela Kashuba, Pharm.D., is a perfect example of the critical role UNC Eshelman School of Pharmacy plays in advancing disease treatment. She chairs the school’s Division of Pharmacotherapy and Experimental Therapeutics and directs the UNC Center for AIDS Research Clinical Pharmacology and Analytical Chemistry Core.

Her work with this group has uncovered gender differences in drug effectiveness that are game changing in optimizing antiretroviral pharmacology for the treatment, prevention and eradication of HIV. Dr. Kashuba is translating discoveries into better education for our students, economic benefits for North Carolina and improved lives for patients worldwide.

 

UNC Eshelman School of Pharmacy Funding Priorities

    Explore More Stories

    A group shot of Owen Fenton and his team in the Fenton Lab
    Faculty Support

    Attracting Expertise

    Owen Fenton sees coming to Carolina as a win for his research interests.

    Tim Willson stands with arms crossed with lab equipment in the background.
    Faculty Support

    Bringing the dark proteome into the light

    A Q&A with Tim Willson, the inaugural Harold Kohn Distinguished Professor in Open Science Drug Discovery

    A UNC Eshelman School of Pharmacy student takes notes during class.
    Health

    Strengthening Diversity, Improving Care

    Grants to the UNC Eshelman School of Pharmacy will support diversity and rural care programs.

    Nate Hathaway in the CRISPR Screening Facility
    Research

    UNC-Chapel Hill Awarded Funding for Study of Malan Syndrome

    UNC Eshelman School of Pharmacy and CRISPR Screening Facility collaborate on Malan Syndrome study.

    Health

    Smarter Organ Transplants

    The UNC Eshelman Institute for Innovation's Venture Studio invested in technology for smarter organ transplants.

    Shawn Hingtgen and Jillian Perry
    Research

    Treating the Untreatable

    New research funded by a NIH grant seeks to combat one of the most treatment-resistant cancers